Literatur

Autor(en) Titel Quelle Links
Takeuchi S, Bartram C, Ludwig R, Royer-Pokora B, Schneider S, Imamura J, Koeffler H Mutations of p53 in Wilms' tumors. Mod Pathol 1995, 8: 483    
Takeuchi S, Bartram C, Seriu T, Miller C, Tobler A, Janssen J, Reiter A, Ludwig W, Zimmermann M, Schwaller J Analysis of a family of cyclin-dependent kinase inhibitors. Blood 1995, 86: 755    
Takeuchi S, Bartram C, Wada M, Reiter A, Hatta Y, Seriu T, Lee E, Miller C, Miyoshi I, Koeffler H Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995, 55: 5377    
Takeuchi S, Bartram C, Miller C, Reiter A, Seriu T, Zimmerann M, Schrappe M, Mori N, Slater J, Miyoshi I, Koeffler H Acute lymphoblastic leukemia of childhood. Blood 1996, 87: 3368    
Takeuchi S, Koike M, Seriu T, Bartram C, Schrappe M, Reiter A, Park S, Taub H, Kubonishi I, Miyoshi I, Koeffler H Frequent loss of heterozygosity on the long arm of chromosome 6 Cancer Res 1998, 58: 2618    
Takeuchi S, Cho S, Seriu T, Koike M, Bartram C, Reiter A, Schrappe M, Takeuchi C, Taguchi H, Koeffler H Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia. Oncogene 1999, 18: 7387    
Takeuchi S, Takeuchi N, Tsukasaki K, Bartram C, Zimmermann M, Schrappe M, Taguchi H, Koeffler H Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia. Br J Haematol 2002, 119: 985    
Takeuchi S, Tsukasaki K, Bartram C, Seriu T, Zimmermann M, Schrappe M, Takeuchi N, Park S, Taguchi H, Koeffler H Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia 2003, 17: 149    
Tallman MS Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia. Leukemia 1996, 10 Supplement 1: 12    
Tallen G, Dworzak M, Gadner H, Masera G, Schrappe M, Biondi A, Vassal G, Pieters R, Jazbec J, Morland B, Creutzig U Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: meeting report of the EC-funded sciencecommunication project DIRECT “Overcoming Cancer with Research” memo (2009) Vol. 2: 234–245    
Tallen G, Dworzak M, Gadner H, Masera G, Haupt R, Eggert A, Schrappe M, Biondi A, Vassal G, Creutzig U More and better cure for an orphan: priorities for future paediatric cancer research in Europe – Meeting report of the EC-funded science-communication project DIRECT “Overcoming Cancer with Research” memo (2009) Vol. 2: 246–254    
Tallen G, Ratei R, Mann G, Kaspers G, Niggli F, Karachunsky A, Ebell W, Escherich G, Schrappe M, Klingebiel T, Fengler R, Henze G, von Stackelberg A Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90. Journal of clinical oncology 2010, 28: 2339    
Tallen G, Henze G, Creutzig U, Dworzak M, Klingebiel T Auswirkungen der EU-Direktive für klinische Studien auf Kinder und Jugendliche mit Krebserkrankungen in Europa. FORUM 2010 25: 42    
Tallroth GA Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate. International archives of allergy and immunology 2011, 154: 356    
Tallen G, Henze G, von Stackelberg A Treatment of children and adolescents with relapsed ALL: therapy target long-term healing. Pharm Unserer Zeit 2012, 41: 214    
Tallen G et al. Musculoskeletal Pain: A New Algorithm for Differential Diagnosis of a Cardinal Symptom in Pediatrics. Klin Pädiatr 2014; 226: 86    
Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, Friedrich C, Langer T, Grabow D, Driever PH, Kortmann RD, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Thomale UW, Krauss J, Mynarek M, von Hoff K, Ottensmeier H, Frühwald M, Kramm CM, Temming P, Müller HL, Witt O, Kordes U, Fleischhack G, Gnekow A, Rutkowski S, German Paediatric Brain Tumour Consortium (HIT-Network) Strategies to improve the quality of survival for childhood brain tumour survivors. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2015, 19: 619    
Tallen G, Riabowol K DisorderING promotes epigenetic order. FEBS letters 2017, 591: 257    
Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig W, Wuchter C High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res 2004, 10: 3737    
Tamannai M, Farhangi S, Truss M, Sinn B, Wurm R, Bose P, Henze G, Riabowol K, von Deimling A, Tallen G The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. Oncology research 2010, 18: 469    
Tamamyan G, Dominkus M, Lang S, Diakos C, Mittheisz E, Horcher E, Holter W, Zoubek A, Bielack S, Kager L Multiple relapses in high-grade osteosarcoma: When to stop aggressive therapy? Pediatric blood & cancer 2015, 62: 529    
Tarbell NJ, Loeffler JS, Silver B, Lynch E, Lavally BL, Kupsky WJ, Scott RM, Sallan SE The change in patterns of relapse in medulloblastoma. Cancer 1991, 68: 1600    
Tartaglia M, Niemeyer C, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht J, Gelb B Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003, 34: 148    
Tarantino MD The treatment of immune thrombocytopenic purpura in children. Current hematology reports 2006, 5: 89    
Taube T Eckert Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia. Comparison with antigen receptor-based MRD quantification methods. Leuk Res 2004    
Tauer JT, Gneuss A, Lohse JE, Jürgens T, Knöfler R Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy. Klinische Padiatrie 2011, 223: 169    
Taylor R, Walker D, Gnekow A, Perilongo G, Zanetti I, Garree M, Kühl J A Preliminary Report of the SIOP/GPOH/UKCCSG Low grade glioma Study. Medical and Pediatric Oncology 1998, 31: 1    
Tegeder I, Thiel K, Erkek S, Johann PD, Berlandi J, Thatikonda V, Frühwald MC, Kool M, Jeibmann A, Hasselblatt M Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors. Journal of neuro-oncology 2019, 141: 43    
Telen MJ, Afenyi-Annan A, Garrett ME, Combs MR, Orringer EP, Ashley-Koch AE Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 2014, Epub ahead of print    
Temming P, Corson TW, Lohmann DR Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand. Future oncology (London, England) 2012, 8: 525    
Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke SL, Eggert A Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. Klinische Padiatrie 2012, 224: 339    
Temming P, Viehmann A, Biewald E, Lohmann DR Sporadic unilateral retinoblastoma or first sign of bilateral disease? Br J Ophthalmol 2013, 97: 475    
Temming P, Eggert A, Bornfeld N, Sauerwein W, Göricke S, Lohmann DR [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision]. Klinische Monatsblatter fur Augenheilkunde 2013, 230: 232    
Temming P, Viehmann A, Arendt M, Eisele L, Spix C, Bornfeld N, Sauerwein W, Jöckel KH, Lohmann DR Pediatric second primary malignancies after retinoblastoma treatment. Pediatric blood & cancer 2015, 62: 1799    
Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Mäusert J, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Lohmann DR, Jöckel KH How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jul 5;    
Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Astrahantseff K, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Jöckel KH, Lohmann DR Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatric blood & cancer 2017, 64: 71    
Tenardi RD, Frühwald MC, Jürgens H, Hertroijs D, Bauer J Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy. Pediatric blood & cancer 2013, 60: 166    
Teofili L, Foà R, Giona F, Larocca LM Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? Haematologica 2008, 93: 169    
Terpe H, Christiansen H, Gonzalez M, Berthold F, Lampert F Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 1995, 31A: 549    
Testi AM, Attarbaschi A, Valsecchi MG, Moericke A, Cario G, Niggli F, Silvestri D, Bader P, Kuhlen M, Parasole R, Putti MC, Lang P, Flotho C, Mann G, Rizzari C, Barisone E, Locatelli F, Linderkamp C, Lauten M, Suttorp M, Zimmermann M, Basso G, Biondi A, Conter V, Schrappe M, AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pediatrica & Berlin-Frankfurt-Muenster) Study Group Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. European journal of cancer (Oxford, England : 1990) 2019, 122: 61    
Rossig C, Jürgens H, Schrappe M, Moericke A, Henze G, von Stackelberg A, Reinhardt D, Burkhardt B, Woessmann W, Zimmermann M, Gadner H, Mann G, Schellong G, Mauz-Koerholz C, Dirksen U, Bielack S, Berthold F, Graf N, Rutkowski S, Calaminus G, Kaatsch P, Creutzig U Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria. Pediatric blood and cancer 2013, 60: 1574    
Teuffel O, Dettling M, Cario G, Stanulla M, Schrappe M, Buhlmann P, Niggli F, Schafer B Gene expression profiles and risk stratification in childhood acute lymphoblastic leukemia. haematologica 2004, 89: 801    
Teuffel O, Stanulla M, Cario G, Ludwig WD, Rottgers S, Schafer BW, Zimmermann M, Schrappe M, Niggli FK Anemia and survival in childhood acute lymphoblastic leukemia. Haematologica 2008, 93: 1652    
Theobald M, Christiansen H, Schmidt A, Melekian B, Wolkewitz N, Christiansen N, Brinkschmidt C, Berthold F, Lampert F Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma. Genes Chromosomes Cancer 1999, 26: 40    
Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B Heterogeneity of the MYCN oncogene in neuroblastoma. Clinical cancer research 2009, 15: 2085    
Thies, K-C, Boos, K Buscher H, Townsend P, Kettler, D Postoperative Schmerztherapie im Kindesalter: Ein internationaler Vergleich. Dtsach arztebl 2009, 97    
Thieme B, Gnekow A Niedriggradige Gliome im Kindesalter. Monatschrift Kinderheilkunde 2008, Volume 156, Number 12, 1173    
Thiel U, Wawer A, Wolf P, Badoglio M, Santucci A, Klingebiel T, Basu O, Borkhardt A, Laws HJ, Kodera Y, Yoshimi A, Peters C, Ladenstein R, Pession A, Prete A, Urban EC, Schwinger W, Bordigoni P, Salmon A, Diaz MA, Afanasyev B, Lisukov I, Morozova E, Toren A, Bielorai B, Korsakas J, Fagioli F, Caselli D, Ehninger G, Gruhn B, Dirksen U, Abdel-Rahman F, Aglietta M, Mastrodicasa E, Torrent M, Corradini P, Demeocq F, Dini G, Dreger P, Eyrich M, Gozdzik J, Guilhot F, Holler E, Koscielniak E, Messina C, Nachbaur D, Sabbatini R, Oldani E, Ottinger H, Ozsahin H, Schots R, Siena S, Stein J, Sufliarska S, Unal A, Ussowicz M, Schneider P, Woessmann W, Jürgens H, Bregni M, Burdach S, on behalf of the Solid Tumor Working Party (STWP) and the Pediatric Disease Working Party (PDWP) of the European Group for Blood and Marrow Transplantation (EBMT), the Asia Pacific Blood and Marrow Transplantation (APBMT), the Pediatric Registry for Stem No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol 2011, 22: 1614    
Thiel U, Wolf P, Wawer A, Blaeschke F, Grunewald TG, von Lüttichau IT, Klingebiel T, Bader P, Borkhardt A, Laws HJ, Handgretinger R, Lang P, Schlegel PG, Eyrich M, Gruhn B, Ehninger G, Koscielniak E, Klein C, Sykora KW, Holler E, Mauz-Körholz C, Woessmann W, Richter GH, Schmidt AH, Peters C, Dirksen U, Jürgens H, Bregni M, Burdach S Human Leukocyte Antigen Distribution in German Caucasians with Advanced Ewing's Sarcoma. Klinische Padiatrie 2012, Epub ahead of print    
Thiel U, Wawer A, von Luettichau I, Bender HU, Blaeschke F, Grunewald TG, Steinborn M, Röper B, Bonig H, Klingebiel T, Bader P, Koscielniak E, Paulussen M, Dirksen U, Jürgens H, Kolb HJ, Burdach SE Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Oncotarget 2016 Oct 25; 7: 70959    
Thompson MP, Kurzrock R Epstein-Barr virus and cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Feb 1; 10: 803    
Thorer H, Zimmermann M, Makarova O, Oschlies I, Klapper W, Lang P, von Stackelberg A, Fleischhack G, Worch J, Jürgens H, Woessmann W, Reiter A, Burkhardt B Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma. Haematologica 2014,    
Thomas C, Ruland V, Kordes U, Hartung S, Capper D, Pietsch T, Gerß J, Wolff JE, Paulus W, Hasselblatt M Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older children. Acta neuropathologica 2015, 129: 925    
Thomas C, Sill M, Ruland V, Witten A, Hartung S, Kordes U, Jeibmann A, Beschorner R, Keyvani K, Bergmann M, Mittelbronn M, Pietsch T, Felsberg J, Monoranu CM, Varlet P, Hauser P, Olar A, Grundy RG, Wolff JE, Korshunov A, Jones DT, Bewerunge-Hudler M, Hovestadt V, von Deimling A, Pfister SM, Paulus W, Capper D, Hasselblatt M Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups. Neuro-oncology 2016, 18: 790    
Thobakgale CF, Ndung'u T Neutrophil counts in persons of African origin. Current opinion in hematology 2014, 21: 50    
Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chretien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia. The New England journal of medicine 2018 Apr 19; 378: 1479    
Thole TM, Toedling J, Sprüssel A, Pfeil S, Savelyeva L, Capper D, Messerschmidt C, Beule D, Groeneveld-Krentz S, Eckert C, Gambara G, Henssen AG, Finkler S, Schulte JH, Sieber A, Bluethgen N, Regenbrecht CRA, Kuenkele A, Lodrini M, Eggert A, Deubzer HE Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease model. International journal of cancer 2019 Jul 15;    
Thomas C, Knerlich-Lukoschus F, Reinhard H, Johann PD, Sturm D, Sahm F, Bens S, Vogt J, Nemes K, Oyen F, Kordes U, Siebert R, Schneppenheim R, Messing-Jünger M, Pietsch T, von Deimling A, Paulus W, Pfister SM, Kool M, Frühwald MC, Hasselblatt M Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1. Acta neuropathologica 2019, 137: 847    
Thomas C, Wefers A, Bens S, Nemes K, Agaimy A, Oyen F, Vogelgesang S, Rodriguez FJ, Brett FM, McLendon R, Bodi I, Burel-Vandenbos F, Keyvani K, Tippelt S, Poulsen FR, Lipp ES, Giannini C, Reifenberger G, Kuchelmeister K, Pietsch T, Kordes U, Siebert R, Frühwald MC, Johann PD, Sill M, Kool M, von Deimling A, Paulus W, Hasselblatt M Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. Acta neuropathologica 2020, 139: 277    
Thomas C, Metrock K, Kordes U, Hasselblatt M, Dhall G Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors. Journal of neuro-oncology 2020, Epup ahead of print    
Tiemann M, Claviez A, Lüders H, Zimmermann M, Schellong G, Dörffel W, Parwaresch R Proliferation characteristics in pediatric Hodgkin's disease point to a cell cycle arrest in G 1 phase. American Journal of Pathology 2004    
Tiemann M, Claviez A, Riener M, Stankewitz K, Dörffel W, Reiter A, Parwaresch R Proliferation rate and outcome in children with T-cell rich B-cell-lymphoma. A clinicopathologic study of the NHL-BFM-study group. Leukemia and Lymphoma 2004    
Tiemann M, Riener MO, Claviez A, Meyer U, Dörffel W, Reiter A, Parwaresch R Proliferation rate and outcome in children with T-cell rich B-cell lymphoma: a clinicopathologic study from the NHL-BFM-study group. Leuk Lymphoma 2005, 46: 1295    
Tiede A [Perioperative hemostasis management]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2007, 78: 69-79; quiz 80    
Tiede A, Rand JH, Budde U, Ganser A, Federici AB How I treat the acquired von Willebrand syndrome. Blood 2011, 117: 6777    
Tillmann B, Krümpelmann S, Wagner A, Schulze-Westhoff P, Jürgens H, Boos J Aufteilung der täglichen Etoposiddosis 50 mg/m2 in 2*25 mg/m2 bewirkt längere Dauer effektiver Serumkonzentrationen. Monatsschr Kinderheilkd 1996, 144:V190-S41    
Tillmann B, Krümpelmann S, Würthwein G, Wagner A, Schulze-Westhoff P, Hempel G, Jürgens H, Boos J Pharmakokinetische Aspekte der oralen Applikation von Etoposid. Klin Pädiatr 1998, 210: 159    
Timmermann B, Kortmann R, Kühl J, Meisner C, Bamberg M Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 2000, 46: 287    
Timmermann B, Kortmann R, Kühl J, Meisner C, Dieckmann K, Pietsch T, Bamberg M Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood. J Clin Oncol 2002, 20: 842    
Timmermann B Therapie von Ependymomen im Kindesalter - Eine aktuelle Übersicht. WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2002, 4: 21    
Timmermann B, Kortmann RD, Kühl J, Willich N, Bamberg M [Interdisciplinary therapy of childhood ependymomas]. Strahlenther Onkol 2002, 178: 469-79.    
Timmermann B, Kortmann RD, Kühl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92. Radiotherapy and oncology 2005, 77: 278    
Timmermann B, Kortmann RD, Kühl J, Rutkowski S, Meisner C, Pietsch T, Deinlein F, Urban C, Warmuth-Metz M, Bamberg M Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. Journal of clinical oncology 2006, 24: 1554    
Timmermann B, Schuck A, Niggli F, Weiss M, Lomax AJ, Pedroni E, Coray A, Jermann M, Rutz HP, Goitein G Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute. International journal of radiation oncology, biology, physics 2007 Feb 1; 67: 497    
Timmermann B Die Protonentherapie. Chancen zur besseren Verträglichkeit der Tumorbestrahlung bei Kindern. Wir 2010, 1: 33    
Timmermann B Ependymome. S1-Leitlinie 025/025, AWMF online 2018    
Timmermann B, Dieckmann K Strahlentherapie. In: Niemeyer C, Eggert A. ed. Pädiatrische Hämatologie und Onkologie Springer; 2018, 199    
Timmermann B Strahlentherapie bei Krebserkrankungen im Kindesalter. Wir 2018, 4: 28 - 31    
Tiphaine AB, Hjalgrim LL, Nersting J, Breitkreutz J, Nelken B, Schrappe M, Stanulla M, Thomas C, Bertrand Y, Leverger G, Baruchel A, Schmiegelow K, Jacqz-Aigrain E Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children. Eur J Pharm Sci 2015 Dec 2; 83: 1-7.    
Tischkowitz MD, Hodgson SV Fanconi anaemia. Med Genet 2003, 40: 1    
Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 2001, 37: 108    
Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Medical and pediatric oncology 2001, 37: 108    
Tomita T, Das L, Radkowski MA Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis. J Neurooncol 1990, 8: 149    
Tomeczkowski J, Beilken A, Frick D, Wieland B, König A, Falk M, Reiter A, Welte K, Sykora K Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. Blood 1995, 86: 1469    
Tomeczkowski J, Yakisan E, Wieland B, Reiter A, Welte K, Sykora K Absence of G-CSF receptors and absent response to G-CSF in childhood Burkitt's lymphoma and B-ALL cells. Br J Haematol 1995, 89: 771    
Tomeczkowski J, Frick D, Schwinzer B, Reiter A, Welte K, Sykora K Expression and regulation of c-kit receptor and proliferative response to stem cell factor in childhood lymphoma and leukemia. Molecular Biology of Hematopoiesis 1996, 173    
Tomeczkowski J, Zur, Reiter A, Welte K, Sykora K Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro. Br J Haematol 1997, 97: 400    
Tomeczkowski J, Frick D, Schwinzer B, Wittner N, Ludwig W, Reiter A, Welte K, Sykora K Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells. Leukemia 1998, 12: 1221    
Tormey CA, Hendrickson JE Routine non-ABO blood group antigen genotyping in sickle cell disease: the new frontier in pretransfusion testing? Transfusion 2015, 55(6 Pt 2): 1374    
Tournade M, de Kraker J, Graf N The SIOP 93-01 Wilms' tumor study. Med Pediatr Oncol 1999    
Tournade M, Com-Nougue C, de Kraker J, Ludwig R, Rey A, Burgers J, Sandstedt B, Godzinski J, Carli M, Potter R, Zucker J International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months. J Clin Oncol 2001, 19: 488    
Tramsen L, Salzmann-Manrique E, Bochennek K, Klingebiel T, Reinhardt D, Creutzig U, Sung L, Lehrnbecher T Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016, 34: 2776    
Treuner J Ifosfamide in the treatment of soft-tissue sarcoma. Am J Hem/Oncol 1993, 521    
Treuner J Die Behandlung der Weichteilsarkome im Kindes- und Jugendalter. Klin Onkol 1994, 44    
Treuner J, Morgan M Clinical management of soft tissue sarcomas. Curr Top Pathol 1995, 89: 17    
Treuner J Weichteilsarkome im Kindes- und Jugendalter; in Schmoll,H-J, Höffken K, Possinger K (Hrsg.) Kompendium internistischer Onkolgie 1996, 1    
Trepel M Neuroanatomie - Struktur und Funktion. Elsevier GmbH, Urban & Fischer Verlag 3. Auflage 2004    
Treuner J, Brecht I Weichteilsarkome. in: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie Springer-Verlag 2006, 865    
Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI, Histiocyte Society Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011, 118: 4577    
Trottestam H, Berglöf E, Horne A, Onelöv E, Beutel K, Lehmberg K, Sieni E, Silfverberg T, Aricò M, Janka G, Henter JI Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta paediatrica (Oslo, Norway : 1992) 2012, 101: 313    
Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH Outcomes for patients with congenital hepatoblastoma. Pediatric blood & cancer 2013, epub ahead of print    
Tucker MA, Meadows AT, Boice JD Jr et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987, 78: 459    
Tulla M, Berthold F, Graf N, Rutkowski S, von Schweinitz D, Spix C, Kaatsch P Incidence, Trends, and Survival of Children With Embryonal Tumors. Pediatrics 2015, 136:e623    
103 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.